178 related articles for article (PubMed ID: 26513611)
1. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
[TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial.
Lu S; Chen J; Zhang R; Luo T; Ma L; Xu P; Ding H; Zeng X; Wu B; Shi Y; Liu C; Mu Y; Chen S; Wang J
Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):5-12. PubMed ID: 38236640
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.
Tadokoro T; Tani J; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Fujita K; Nomura T; Morishita A; Kobara H; Himoto T; Ono M; Masaki T
Sci Rep; 2024 May; 14(1):10784. PubMed ID: 38734732
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
[TBL] [Abstract][Full Text] [Related]
6. Statin use in cirrhosis and its association with incidence of portal vein thrombosis.
Amjad W; Jiang Z; Lai M
J Gastroenterol Hepatol; 2024 May; 39(5):955-963. PubMed ID: 38273643
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation for the Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis of Comparative Studies.
Yao C; Zhao M; Ibrahim B; Saab S
J Clin Exp Hepatol; 2023; 13(3):404-413. PubMed ID: 37250883
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for Stroke Prevention in Atrial Fibrillation and Treatment of Venous Thromboembolism and Portal Vein Thrombosis in Cirrhosis: Guidance from the SSC of the ISTH.
Carlin S; Cuker A; Gatt A; Gendron N; Hernandez-Gea V; Meijer K; Siegal DM; Stanworth S; Lisman T; Roberts LN
J Thromb Haemost; 2024 May; ():. PubMed ID: 38823454
[TBL] [Abstract][Full Text] [Related]
9. Portal Vein Thrombosis: State-of-the-Art Review.
Boccatonda A; Gentilini S; Zanata E; Simion C; Serra C; Simioni P; Piscaglia F; Campello E; Ageno W
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592411
[No Abstract] [Full Text] [Related]
10. Portal vein thrombosis: What surgeons need to know.
Quarrie R; Stawicki SP
Int J Crit Illn Inj Sci; 2018; 8(2):73-77. PubMed ID: 29963409
[TBL] [Abstract][Full Text] [Related]
11. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.
Mantaka A; Augoustaki A; Kouroumalis EA; Samonakis DN
Ann Gastroenterol; 2018; 31(3):315-329. PubMed ID: 29720857
[TBL] [Abstract][Full Text] [Related]
12. Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis.
Amjad W; Jiang ZG; Lai M
Eur J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38829950
[TBL] [Abstract][Full Text] [Related]
13. Plantar vein thrombosis: 17-year longitudinal study of consecutive patients from a Swiss academic center.
Serifi M; Kaufmann PA; Fumagalli RM; Kobe A; Kucher N; Barco S
Res Pract Thromb Haemost; 2024 Mar; 8(3):102396. PubMed ID: 38694839
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary vein thrombosis: Clinical presentation and outcomes.
Sykora D; Churchill RA; Hodge DO; Callori S; Houghton DE; McBane RD; Wysokinski WE
Thromb Res; 2024 Jul; 239():109028. PubMed ID: 38735167
[TBL] [Abstract][Full Text] [Related]
15. Treatment of portal vein thrombosis in cirrhosis with anticoagulation-more than meets the eye?
Lisman T
Hepatobiliary Surg Nutr; 2024 Apr; 13(2):321-324. PubMed ID: 38617493
[No Abstract] [Full Text] [Related]
16. Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management Strategies.
Hilscher MB; Wysokinski WE; Andrews JC; Simonetto DA; Law RJ; Kamath PS
Gastroenterology; 2024 May; ():. PubMed ID: 38801909
[No Abstract] [Full Text] [Related]
17. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
Loffredo L; Pastori D; Farcomeni A; Violi F
Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
[TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.
Intagliata NM; Henry ZH; Maitland H; Shah NL; Argo CK; Northup PG; Caldwell SH
Dig Dis Sci; 2016 Jun; 61(6):1721-7. PubMed ID: 26725062
[TBL] [Abstract][Full Text] [Related]
19. Direct Oral Anticoagulants in Cirrhosis.
Intagliata NM; Maitland H; Caldwell SH
Curr Treat Options Gastroenterol; 2016 Jun; 14(2):247-56. PubMed ID: 27020266
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation in Patients With Cirrhosis: Caught Between a Rock-Liver and a Hard Place.
Ha NB; Regal RE
Ann Pharmacother; 2016 May; 50(5):402-9. PubMed ID: 26861989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
